Sight Sciences (SGHT) COO sells 12,728 shares to cover RSU tax obligations
Rhea-AI Filing Summary
Sight Sciences, Inc. Chief Operating Officer Alison Bauerlein reported a sale of 12,728 shares of Common Stock on May 18, 2026 at a weighted average price of $5.12 per share. According to the disclosure, these shares were sold to cover her tax liability arising from recently vested restricted stock units.
After this tax-related sale, Bauerlein directly holds 688,893 shares, which includes 169,810 shares of Common Stock and 519,083 shares that are scheduled to be issued as her remaining RSUs vest and settle over time.
Positive
- None.
Negative
- None.
Insights
COO’s sale is a routine tax-related disposition tied to RSU vesting.
COO Alison Bauerlein sold 12,728 shares of Sight Sciences Common Stock at a weighted average of $5.12 per share. Footnote language states the sale was made to cover tax liabilities from vesting restricted stock units, a common administrative step in equity compensation.
Following the transaction, she reports 688,893 shares, including 519,083 shares that will be issued upon future RSU vesting. The sold amount is small relative to her reported position, and the filing frames it as tax-driven rather than a discretionary portfolio change.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 12,728 | $5.12 | $65K |
Footnotes (1)
- Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $4.91 to $5.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 169,810 shares of Common Stock, and (ii) 519,083 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.